Jones from Malta

Registered at the short selling broker Pepperstone, 5 minutes ago.

» Try Pepperstone you too
78.6% of retail investor accounts lose money when trading spread bets and CFDs with Pepperstone.
Don't show again

Neuronetics Inc (STIM) shares information

Neuronetics Inc


24h Change

-5.64 %

STIM

Live rate: Market closed

Stock data per Monday 10 May, 2021

STIM
NASDAQ/NMS (GLOBAL MARKET)
13.84
13.06
-0.78 (-5.64%)
US Market is closed

Live Stock price in graph for Neuronetics Inc (STIM)

  • Latest Volume

    608,083 (-38.5 %)

  • Volume prev. day

    988,800

  • Avg. daily volume

    665,383

  • Market cap

    336,424,229

  • P/E ratio

    n/a

  • Today high

    n/a

  • Today low

    12.83 USD

  • 52 week high

    22.43 USD

  • 52 week low

    1.7 USD

  • YTD Change

    + 18.94 %

Quick links

 

Latest news about Neuronetics Inc

Below you can find the most recent news posts about Neuronetics Inc, primarily from US and UK based news sources.

Why Cocrystal Pharma, Chemocentryx, Neuronetics And BioLineRx Are Moving Today

Tuesday, 4 May 2021, 19:45:43
Cocrystal Pharma, Inc. (NASDAQ: COCP ), ChemoCentryx, Inc. (NASDAQ: CCXI ), Neuronetics, Inc. (NASDAQ: STIM ) and BioLineRx Ltd. (NASDAQ: BLRX ) are among the biggest health care movers Tuesday. Cocrystal Shines On COVID-19 Pipeline: Cocrystal, a clinical-stage biotech engaged in the development of anti-viral therapeutics, announced Monday it is aggressively developing novel coronavirus protease inhibitors for COVID-19 prophylactic and therapeutic use. “These drug candidates bind to a highly conserved region of the active site of SARS-CoV-2 protease that is required for SARS-CoV-2 viral replication,” the company said. Due to their novel mechanism of action, these protease inhibitors are likely to be effective against new variants of SARS-CoV-2, it added. After a muted reaction on Monday, the stock has taken off Tuesday. Reacting … Full story available on Benzinga.com
— Benzinga


Neuronetics: Q4 Earnings Insights

Tuesday, 2 March 2021, 08:57:00
Shares of Neuronetics (NASDAQ:STIM) remained unaffected after the company reported Q4 results. Quarterly Results Earnings per share were up 53.66% …
— Benzinga


Neuronetics Must-See Earnings Estimates for: Stock market Insights & financial analysis

Tuesday, 2 March 2021, 07:01:00
Neuronetics announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
— Stock Market Daily


The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa

Friday, 22 January 2021, 13:22:33
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 21) Acasti Pharma Inc (NASDAQ: ACST ) Alimera Sciences Inc (NASDAQ: ALIM ) argenx SE – ADR (NASDAQ: ARGX ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) AzurRx BioPharma Inc (NASDAQ: AZRX ) Chimerix Inc (NASDAQ: CMRX ) Edap Tms SA (NASDAQ: EDAP ) Eli Lilly And Co (NYSE: LLY ) (announced positive results for its COVID-19 antibody treatment) ESSA Pharma Inc (NASDAQ: EPIX ) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Inari Medical Inc (NASDAQ: NARI ) INmune Bio Inc (NASDAQ: INMB ) ( INSM ) Integra Lifesciences Holdings Corp (NASDAQ: IART ) Inventiva ADR Representing Ord Shs (NASDAQ: IVA ) Jounce Therapeutics Inc (NASDAQ: JNCE ) Krystal Biotech Inc (NASDAQ: KRYS ) Laboratory Corp. of America Holdings (NYSE: LH ) Merus NV (NASDAQ: MRUS ) Neuronetics Inc (NASDAQ: STIM ) OncoSec Medical Inc (NASDAQ: ONCS ) (announced common stock offering) PRA Health Sciences Inc (NASDAQ: PRAH ) Precision BioSciences Inc (NASDAQ: DTIL ) Profound Medical Corp (NASDAQ: PROF ) Renalytix AI PLC (NASDAQ: RNLX ) Rhythm Pharmaceuticals Inc (NASDAQ: RYTM ) Seelos Therapeutics Inc (NASDAQ: SEEL ) Surface Oncology Inc (NASDAQ: SURF ) Syneos Health Inc (NASDAQ: SYNH ) Synlogic Inc (NASDAQ: SYBX ) Twist Bioscience Corp (NASDAQ: TWST ) Vericel Corp (NASDAQ: VCEL ) Xencor Inc (NASDAQ: XNCR ) Down In The Dumps None of the biotech/medical device/diagnostic stocks hit 52-week highs in the session.
— Benzinga


The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica

Tuesday, 29 December 2020, 14:09:37
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 28) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Allakos Inc (NASDAQ: ALLK ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Arvinas Inc (NASDAQ: ARVN ) Atea Pharmaceuticals, Inc. (NASDAQ: AVIR ) AtriCure Inc. (NASDAQ: ATRC ) BIO-TECHNE Corp (NASDAQ: TECH ) BridgeBio Pharma Inc (NASDAQ: BBIO ) Cellectis SA (NASDAQ: CLLS ) Crispr Therapeutics AG (NASDAQ: CRSP ) Curis, Inc. (NASDAQ: CRIS ) Edwards Lifesciences Corp (NYSE: EW ) ESSA Pharma Inc (NASDAQ: EPIX ) Eton Pharmaceuticals Inc (NASDAQ: ETON ) Evelo Biosciences Inc (NASDAQ: EVLO ) Evogene Ltd (NASDAQ: EVGN ) Inari Medical Inc (NASDAQ: NARI ) Integra Lifesciences Holdings Corp (NASDAQ: IART ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Jazz Pharmaceuticals PLC (NASDAQ: JAZZ ) Kodiak Sciences Inc (NASDAQ: KOD ) Kymera Therapeutics Inc (NASDAQ: KYMR ) Lumos Pharma Inc (NASDAQ: LUMO ) Medicenna Therapeutics Corp (NASDAQ: MDNA ) Myovant Sciences Ltd (NYSE: MYOV ) – announced a licensing deal with Pfizer Inc.
— Benzinga


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have STIM available or trade one of the many other CFD stocks they have.
Risk warning: 71.2% of retail investor accounts lose money when trading CFDs with Capital.